- Report
- January 2024
- 257 Pages
Global
From €3238EUR$3,500USD£2,723GBP
€4625EUR$5,000USD£3,890GBP
- Report
- March 2023
- 356 Pages
Global
From €3238EUR$3,500USD£2,723GBP
€4625EUR$5,000USD£3,890GBP
- Report
- February 2024
- 110 Pages
Global
From €4394EUR$4,750USD£3,695GBP
- Report
- January 2024
- 145 Pages
Global
From €3932EUR$4,250USD£3,306GBP
- Report
- January 2025
- 85 Pages
Saudi Arabia
From €3238EUR$3,500USD£2,723GBP
- Report
- November 2022
- 111 Pages
Global
From €4163EUR$4,500USD£3,501GBP
- Report
- November 2023
- 630 Pages
Global
From €8788EUR$9,500USD£7,391GBP
- Report
- April 2024
- 185 Pages
Global
From €4163EUR$4,500USD£3,501GBP
- Report
- February 2025
- 178 Pages
India
From €2313EUR$2,500USD£1,945GBP
- Report
- December 2022
- 112 Pages
Global
From €4163EUR$4,500USD£3,501GBP
- Report
- April 2023
- 120 Pages
Global
From €4394EUR$4,750USD£3,695GBP
- Report
- February 2024
- 115 Pages
Global
From €4394EUR$4,750USD£3,695GBP
- Report
- April 2023
- 110 Pages
Global
From €4394EUR$4,750USD£3,695GBP
- Report
- January 2022
- 120 Pages
Global
From €4394EUR$4,750USD£3,695GBP
- Report
- May 2024
- 183 Pages
Global
From €4163EUR$4,500USD£3,501GBP
- Report
- October 2023
- 88 Pages
India
From €3238EUR$3,500USD£2,723GBP
- Report
- March 2024
- 200 Pages
Global
From €3839EUR$4,150USD£3,229GBP
- Report
- October 2023
- 172 Pages
Global
From €4163EUR$4,500USD£3,501GBP
- Report
- May 2023
- 147 Pages
Global
From €4578EUR$4,949USD£3,850GBP
- Report
- August 2022
- 202 Pages
Global
From €3330EUR$3,600USD£2,801GBP

Colorectal cancer is a type of cancer that affects the colon and rectum. It is the third most common type of cancer in the world and is the second leading cause of cancer-related deaths in the United States. Treatment for colorectal cancer typically involves surgery, chemotherapy, and radiation therapy. In recent years, targeted therapies and immunotherapies have been developed to treat colorectal cancer.
The oncology market for colorectal cancer is highly competitive, with a number of companies offering treatments and therapies. These include pharmaceutical companies such as Merck, Bristol-Myers Squibb, and Roche, as well as biotechnology companies such as ImmunoGen, Exelixis, and Incyte. Additionally, medical device companies such as Medtronic and Boston Scientific are involved in the development of treatments for colorectal cancer. Show Less Read more